Journal Ranking
#522
/ 33,944
📊 Below Average
Overall Score
41.4/100
Score Breakdown
Engagement
31
Accessibility
35
Timeliness
50
Diversity
30
Innovation
40
Community Impact
37
Ethics & Transparency
0
Content Quality
0
Editorial Diversity
0
Publication Regularity
0
Geographic Reach
0
30-Day Activity
Page Views
22
Unique Visitors
22
Updated 3 days ago
OncoTargets and therapy
Login or register to claim ownership or editorship of this journal.
Quality Widget - Embed on Your Website
Display your journal's quality scores on your website with our beautiful, self-contained widget. Choose between two embedding methods below.
One-Line JavaScript Embed (Recommended):
Advantages:
- ✅ Simpler integration (just one line of code)
- ✅ Better SEO (content is in same DOM)
- ✅ No iframe limitations
- ✅ Fully self-contained (no dependencies)
- ✅ Works on any website regardless of CSS framework
- ✅ Clickable badges link to full journal page
iFrame Embed Code:
Limitations:
- ⚠️ Display-only (scores not clickable due to iframe constraints)
- ⚠️ May have SEO limitations
- ⚠️ Potential CORS/CSP issues on some websites
Preview:
| Indexings |
ncbi
doaj
ulakbim
sci
|
|---|---|
| Short Name | Onco Targets Ther |
| Abbreviated Name | oncotargets and therapy |
| ISSN | 1178-6930 |
| Aim and Scope |
|
| URL | http://www.dovepress.com/oncotargets-and-therapy-journal |
| Author Instructions |
Publications Per Year
Recent Articles (24 total)
2015
Vol. 8
, pp. 1533--1541
450 views
DOI
Abstract
2015
Vol. 8
, pp. 1533-1541
419 views
DOI
Abstract
2019
Vol. Volume 12
, pp. 4281-4285
391 views
Abstract
2015
Vol. 8
, pp. 157--168
383 views
DOI
Abstract
2019
Vol. 12
, pp. 5449-5455
378 views
DOI
Abstract
2015
Vol. 8
, pp. 157-168
377 views
DOI
Abstract
2020
Vol. 13
, pp. 309-321
346 views
DOI
Abstract
2019
Vol. 12
, pp. 5989-6000
336 views
DOI
Abstract
2020
FANCI Cooperates with IMPDH2 to Promote Lung Adenocarcinoma Tumor Growth via a MEK/ERK/MMPs Pathway.
Vol. 13
, pp. 451-463
287 views
DOI
Abstract
2019
Vol. Volume 12
, pp. 4741-4753
279 views
Abstract